|40.50||+0.39 / +0.97%|
As of 3:59pm ET
|40.50||0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 41.00, with a high estimate of 46.00 and a low estimate of 35.00. The median estimate represents a +1.23% increase from the last price of 40.50.
The current consensus among 6 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.